factual
Moderna repurposed influenza platform for COVID
Moderna had a mRNA influenza vaccine program already built, which allowed the company to swap the influenza sequence for the SARS-CoV-2 sequence quickly, because the surrounding infrastructure was already in place.
factualpending
Speaker
Jeff CollerEvidence Quote
“Moderna, for example, was testing a vaccine for influenza. That allowed them... to quickly change the influenza sequence out for the COVID sequence”
Created: 11/17/2026, 7:10:08 AM
Your notes
Loading notes...